These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 13540973)

  • 21. Vibrational spectroscopic studies and ab initio calculations of sulfanilamide.
    Varghese HT; Panicker CY; Philip D
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Sep; 65(1):155-8. PubMed ID: 16458050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical powders analysis using FT-Raman spectrometry: simultaneous determination of sulfathiazole and sulfanilamide.
    López-Sánchez M; Ruedas-Rama MJ; Ruiz-Medina A; Molina-Díaz A; Ayora-Cañada MJ
    Talanta; 2008 Feb; 74(5):1603-7. PubMed ID: 18371824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of uremia resulting from anuria caused by sulfanilamide therapy].
    BURSHTEIN AZ
    Klin Med (Mosk); 1957 Feb; 35(2):155-6. PubMed ID: 13429806
    [No Abstract]   [Full Text] [Related]  

  • 24. [Colorimetric determination of phenacetin and sulfanilamide].
    DI BACCO G
    Boll Chim Farm; 1954 Oct; 93(10):366-9. PubMed ID: 13230244
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary study on sulfanilamide metabolism].
    BOYER F; SAVIARD M; DECHAVASSINE M
    C R Hebd Seances Acad Sci; 1955 May; 240(20):2023-4. PubMed ID: 14390786
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical aspects of sulfanilamide-induced polyneuritis].
    PREZA B
    Bul Univ Shtet Tiranes Ser Shk Mjekesore; 1961; 1(3)():11-26. PubMed ID: 14038492
    [No Abstract]   [Full Text] [Related]  

  • 27. [Isolation and identification of N1-acetyl-p-aminophenylsulfamide in the urine of sulfanilamide-treated rats].
    MILHAUD G; AUBERT JP; BOYER F
    C R Hebd Seances Acad Sci; 1955 May; 240(21):2090-1. PubMed ID: 14390796
    [No Abstract]   [Full Text] [Related]  

  • 28. [On side effects of therapeutic doses of sulfanilamide preparations on the central nervous system in humans].
    RIAZANOVA-SOLNTSEVA MS
    Farmakol Toksikol; 1960; 23():234-8. PubMed ID: 13741174
    [No Abstract]   [Full Text] [Related]  

  • 29. The preparation and antioxidant activity of the sulfanilamide derivatives of chitosan and chitosan sulfates.
    Zhong Z; Ji X; Xing R; Liu S; Guo Z; Chen X; Li P
    Bioorg Med Chem; 2007 Jun; 15(11):3775-82. PubMed ID: 17428668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effectiveness of allantoin-sulfanilamide; 9 aminoacridine cream in suppository form.
    PONTARELLI DJ
    Del Med J; 1961 Jan; 33():1-3. PubMed ID: 13737018
    [No Abstract]   [Full Text] [Related]  

  • 31. [Marked physical and roentgenological changes in the lungs in croupous pneumonia, treated with sulfanilamide preparations and antibiotics].
    FEDOTOV PI
    Klin Med (Mosk); 1961 Jun; 39():106-10. PubMed ID: 13698569
    [No Abstract]   [Full Text] [Related]  

  • 32. STUDIES ON THE SITES OF ACTIONS OF SULFANILAMIDE DERIVATIVES AND TETRACYCLINE, AND ON THE BIOCHEMICAL MECHANISMS OF RESISTANCE TO THESE DRUGS, IN BACTERIA.
    YOKOTA T
    Jpn J Med Sci Biol; 1963 Aug; 16():230-1. PubMed ID: 14071907
    [No Abstract]   [Full Text] [Related]  

  • 33. Polymeric drug based on sulfanilamide: synthesis, antimicrobial and drug releasing studies.
    Umamaheswara Reddy C; Arun A; Amalraj A; Reddy BS
    J Pharm Pharmacol; 2007 Sep; 59(9):1207-13. PubMed ID: 17883891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report.
    Bristol I; Brown J; Slomovitz BM; Shannon VR; Eifel PJ
    Gynecol Oncol; 2005 Jun; 97(3):953-6. PubMed ID: 15907987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of polymorphic differences for sulfanilamide, as seen through 13C and 15N solid-state NMR, together with shielding calculations.
    Portieri A; Harris RK; Fletton RA; Lancaster RW; Threlfall TL
    Magn Reson Chem; 2004 Mar; 42(3):313-20. PubMed ID: 14971016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of various components of coenzyme A on the acetylation of p-aminobenzensulfonamide].
    AMBANELLI U; SALVI G
    G Clin Med; 1956 Dec; 37(12):1816-31. PubMed ID: 13415402
    [No Abstract]   [Full Text] [Related]  

  • 37. The inhibition of sulphanilamide acetylation by aromatic and heterocyclic carboxamides and carboxhydrazides.
    JOHNSON WJ
    Can J Biochem Physiol; 1955 Mar; 33(2):107-11. PubMed ID: 14352015
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate.
    AXELROD J; REICHENTHAL J; BRODIE BB
    J Pharmacol Exp Ther; 1954 Sep; 112(1):49-54. PubMed ID: 13192608
    [No Abstract]   [Full Text] [Related]  

  • 39. ANTI-CATALASE AND THE MECHANISM OF SULFANILAMIDE ACTION.
    Locke A; Main ER; Mellon RR
    Science; 1938 Dec; 88(2296):620-1. PubMed ID: 17788576
    [No Abstract]   [Full Text] [Related]  

  • 40. THE MODE OF ACTION OF SULFANILAMIDE AND PRONTOSIL.
    Finkelstein R; Birkeland JM
    Science; 1938 May; 87(2263):441-2. PubMed ID: 17781041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.